How to Buy a Hospice Agency: An Acquisition Guide

Hospice is one of the most attractive healthcare verticals for acquirers right now — and one of the most treacherous. The economics are compelling: Medicare reimbursement is relatively predictable, demand is growing with an aging population, and well-run agencies generate strong margins. But the regulatory complexity can destroy a deal if you don't know where to look.

I've advised on dozens of hospice transactions over the years, and I've watched buyers lose millions by missing issues that should have been caught in diligence. Here is what you actually need to evaluate before you sign a letter of intent.

Medicare Certification Transfer: The Deal Gate

Every hospice agency operating in the US must hold a Medicare provider number — a CMS Certification Number (CCN). Without it, the agency cannot bill Medicare, which typically represents 85-95% of revenue. When you acquire a hospice, you are fundamentally acquiring that CCN.

There are two paths to structuring this, and they have wildly different risk profiles.

Asset purchase with CHOW (Change of Ownership).In most hospice acquisitions, the buyer purchases the agency's assets and files a CHOW application with CMS. The existing CCN transfers to the new owner. CMS processes the CHOW, the Medicare Administrative Contractor (MAC) updates billing records, and — in theory — it's seamless. In practice, CHOW processing takes 60-120 days, and during that window you may face billing delays. I've seen closings delayed by six months because CMS lost paperwork. Build this timeline into your purchase agreement.

Stock or membership interest purchase.If you buy the entity itself (LLC membership units or corporate stock), the CCN stays with the entity and no CHOW is needed. This is faster but carries a critical risk: you inherit all of the entity's liabilities, including any pending compliance issues, overpayment demands, or fraud investigations. In hospice, where OIG scrutiny is intense, this is not a theoretical concern.

My recommendation: structure as an asset deal with CHOW unless you have a very specific reason to buy the entity, and build adequate escrow holdbacks to cover the transition period.

Census Verification: What You're Actually Buying

The Average Daily Census (ADC) is the single most important operating metric in hospice. It tells you how many patients are on service on any given day, and it directly drives revenue. A hospice with an ADC of 100 patients at the 2026 routine home care rate of roughly $213/day generates about $7.8M in annual revenue.

But ADC is easy to manipulate in the short term. Sellers know that census is what buyers pay for, so they have every incentive to inflate it leading up to a sale. Here is what I look for.

Monthly census trending over 24 months. A sudden ADC spike in the 6 months before a sale is a red flag. Organic growth looks like a steady upward line, not a hockey stick.

Admission and discharge patterns.Healthy agencies have a steady ratio of admissions to discharges (deaths, revocations, transfers). If admissions spiked recently but discharge patterns didn't change proportionally, someone may be admitting patients who don't meet hospice eligibility criteria — which is both unsustainable and a compliance risk.

Average length of stay (ALOS).This is where regulators focus, and you should too. The national average ALOS is around 70-90 days. If the agency's ALOS is significantly above that — say 120+ days — it could indicate that patients are being kept on service who no longer meet the terminal prognosis requirement. OIG has made long-stay hospice patients a top audit priority.

Referral source concentration.Where are patients coming from? If 40%+ of admissions come from a single hospital system or physician group, that's a concentration risk that should be reflected in your valuation. Referral relationships often follow individual sales reps, not the agency brand.

Star Ratings and Quality Metrics

CMS publishes Hospice Compare data including quality measures and, starting in recent years, star ratings based on CAHPS (Consumer Assessment of Healthcare Providers and Systems) surveys. These ratings are publicly available and directly affect referral patterns.

A 4-5 star agency will have an easier time winning referrals from hospitals and physician groups that are increasingly tracking quality metrics for their discharge partners. A 1-2 star agency has a structural headwind that will cost you money to fix.

Beyond stars, look at the HQRP quality measures and pull the agency's survey history from your state health department. Condition-level deficiencies on the most recent survey are a serious concern. Immediate jeopardy citations in the past three years should be a deal-breaker unless you have a very clear remediation plan.

Certificate of Need Requirements

This is where hospice acquisitions diverge sharply from other healthcare deals. Several states — including Alabama, Georgia, Kentucky, Mississippi, Montana, North Carolina, South Carolina, Tennessee, and Washington — require a Certificate of Need (CON) to operate a hospice. In CON states, the hospice license itself has significant independent value because the state limits new market entrants.

In a CON state, you're not just buying a business — you're buying a government-granted right to operate that your competitors cannot easily replicate. This typically adds 1-2x to the EBITDA multiple compared to the same agency in a non-CON state.

But CON transfer rules vary by state. Some states treat asset acquisitions as a new CON application (requiring a full review process that can take 6-18 months). Others allow expedited transfer with a change of ownership. You need state-specific legal counsel on this — not your general corporate attorney.

Compliance History: What the Seller Won't Volunteer

Hospice is under more regulatory scrutiny than almost any other healthcare sector right now. OIG has identified hospice fraud as a top enforcement priority, and the Medicare Payment Advisory Commission has been recommending reimbursement reforms for years. Before you buy, you need to dig into compliance history with the same rigor you'd apply to a full due diligence process.

Request the agency's compliance program documentation — written compliance plan, designated compliance officer, staff training records, internal audit results, and reporting mechanism. If these don't exist, the agency has been operating without guardrails. Check the OIG exclusions database (LEIE) for every physician, administrator, and clinical director. Employing an excluded individual — even unknowingly — triggers per-day civil monetary penalties.

Ask specifically about any prior or pending RAC audits, ZPIC investigations, or MAC post-payment reviews. These can result in recoupment demands of hundreds of thousands of dollars, and the liability may transfer to you depending on deal structure. Pull the agency's Medicare cost reports for the last three years and compare reported costs against the seller's financial statements. Discrepancies are common and always worth investigating.

Staffing Assessment: The Hidden Risk

Hospice is a people business. Every patient on census requires a coordinated care team — physician oversight, nursing visits, social work, chaplain services, aide visits, and bereavement support. When you acquire a hospice, you need to evaluate whether the staffing model is sustainable or stretched to the breaking point.

Calculate the RN-to-patient ratio. Industry standard is roughly 1 RN case manager per 12-15 patients. If the agency is running at 1:20 or higher, nurses are burned out, documentation is suffering, and you'll face turnover immediately after closing.

The medical director relationship deserves special attention. Many agencies rely on a single medical director for all certifications and recertifications. If that physician leaves after the sale, you have an immediate operational crisis. Understand the contractual relationship, compensation, and whether backup physicians are in place. Similarly, a Director of Nursing with years of tenure carries institutional knowledge that cannot be replaced. Retention agreements for key clinical staff should be part of your deal structure.

The Bottom Line on Hospice Acquisitions

Hospice is a fundamentally good business with strong secular tailwinds. The 65+ population is growing, hospice election rates continue to increase, and Medicare reimbursement — while not generous — is predictable and reliable. Well-run agencies generate 15-20% EBITDA margins with high revenue visibility.

But the regulatory environment is unforgiving. A compliance issue you missed in diligence can result in payment suspensions, exclusion from Medicare, or criminal prosecution. The agencies trading at 8-12x EBITDA in today's market are the ones with clean survey histories, stable census, reasonable ALOS, strong star ratings, and deep clinical teams. If you find one of those, move fast — because someone else is already looking at it.